CDR Life Sciences Litigation Symposium June 2019

• Life Sciences
• CRA Insights

ESMO 2025 Review: Bring me the horizon

From these sessions, CRA’s Aaron Everitt highlighted that while there are still relevant data releases and findings on existing immune checkpoint inhibitors,...

• Life Sciences
• CRA Insights

GLP-1 access is shifting – Are stakeholders ready?

CRA’s Becky Davis examines how these dramatic price reductions, combined with Direct-to-Patient distribution models, may be accelerating employer migration...

• International Arbitration
• Speaking Engagement

• November 27, 2025
• Milan, Italy

16th CAM Annual Conference

Greg Bell is a panelist during the session titled “Navigating Life Sciences disputes. An arbitrator’s perspective.” For more information on this event, click...

• European Competition
• Sponsorship & Speaking Engagement

• December 2, 2025
• Brussels, Belgium

InformaConnect: CompLaw Pharma

CRA is a proud sponsor of the event covering divisional patent strategies, denigration, Article 102, enforcement, mergers, distribution, as well as...